CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Science: Disrupt | The Responsible Science Podcast Series

Read More
All Posts

We're excited to partner with Science: Disrupt to present a five-part podcast exploring what "Responsible Science" means amid the reproducibility crisis.

Episode 1: Overview

Guest: Stephen Buranyi, Guardian Longread contributor

“When I’m talking about the replication crisis, what I mean is science done in a way that is not replicable because the experiments are not very valid. And they’re not valid because you’ve essentially replicated them poorly yourself. You cherry picked in some way, etcetera. It’s not that it’s not replicable because you’re not sharing enough about it. One of those things has an easy fix: one is a cultural effect and one is a technological effect.” ~ Stephen Buranyi

 


Episode 2: The Disruptors

Guests: 

  • Lenny Teytelman, Co-Founder and CEO of Protocols.io – an open-access repository for science methods
  • Ben Miles, Head of Product at Transcriptic – the robotic cloud laboratory
  • Tom Leung, Founder and CSO of BenchSci – AI-driven software for antibody search 

 


Episode 3: The Industry

Guests:

  • Josh Ghaim, CTO of Consumer R&D at Johnson & Johnson
  • Roby Polakiewicz, CSO at Cell Signaling Technology

 


Episode 4: Publishing

Guests: 

  • Alison Mudditt, CEO of PLOS
  • Ivan Oransky, Co-Founder of Retraction Watch
  • Richard Sever, Co-Founder of bioRxiv

 


Episode 5: The Next Generation

 


Cell Signaling Technology
Cell Signaling Technology
CST is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. CST is a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our customers, our communities, and our planet.

Recent Posts

Hallmarks of Cancer: Nonmutational Epigenetic Reprogramming

Nonmutational epigenetic reprogramming is a defining characteristic of cancer, whereby tumor cells acquir...
Curtis Desilets Nov 5, 2025

CiteAb Top 100: The Top-Ranked Recombinant Antibodies & Discovery Reagents

Each year, the CiteAb Top 100 Antibodies report highlights the reagents cited most frequently in publishe...
Alexandra Foley Oct 31, 2025

Hallmarks of Cancer: Unlocking Phenotypic Plasticity

In 2022, an update was made to the Hallmarks of Cancer framework to expand beyond the eight hallmarks and...
Antony Wood, PhD Oct 22, 2025